Tag | Content |
---|
EnhancerAtlas ID | HS106-01224 | Organism | Homo sapiens | Tissue/cell | iPSC | Coordinate | chr2:70993930-70994730 | TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEF2A | MA0052.3 | chr2:70994105-70994117 | TCTATTTTTAGT | - | 6.27 | MEF2B | MA0660.1 | chr2:70994105-70994117 | TCTATTTTTAGT | - | 6.32 | MEF2C | MA0497.1 | chr2:70994104-70994119 | TTCTATTTTTAGTTT | - | 7.18 | ZNF263 | MA0528.1 | chr2:70994329-70994350 | AAGGGAGGGGAGGCAGGGAGA | + | 6.07 | ZNF263 | MA0528.1 | chr2:70994217-70994238 | TGCCCCTCCCTCCCTTCCCCC | - | 6.07 | ZNF263 | MA0528.1 | chr2:70994628-70994649 | GAAGGAAAGAGAGGGGAGGGG | + | 6.08 | ZNF263 | MA0528.1 | chr2:70994338-70994359 | GAGGCAGGGAGAGGAGAGGGA | + | 6.73 | ZNF263 | MA0528.1 | chr2:70994639-70994660 | AGGGGAGGGGAGGGAGGGGAG | + | 7.13 | ZNF263 | MA0528.1 | chr2:70994644-70994665 | AGGGGAGGGAGGGGAGGGGAG | + | 7.59 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| Enhancer Sequence | TAAAGCTCAT CTGAGTCAGT TGAATCTTAG ACGACAAACA GCAAGAGGGA AGAGTGGGTG 60 TAAGGAAACA GATGGGTATT AATCATGTGT CAGAGATAAA TGACAGTTTT TTAAAGAATT 120 TGATAGGGTG TGGGCTGGAG CTTGCTTTTT TATTTTCTAT TTCTATTTCC TATTTTCTAT 180 TTTTAGTTTT GGGCAAGAGA TGGAGATTAG GGGTGAGAAA AGGAAGGAAG AGAAAAGGCA 240 AGACAATAGG CCAGACCCGA GAGCCTGATC TGCATCCTAA AGCAGTCTGC CCCTCCCTCC 300 CTTCCCCCCA ACACCAGGTA GGCTGTGGTG TGATTTAAAA ATAAGCAGAC ACCGACTCCC 360 GCCTCCGGGA CCGGGGATGG CCTCCGCCCC GGCTGCAGAA AGGGAGGGGA GGCAGGGAGA 420 GGAGAGGGAA GATGGAAGAA ACAGACTGGC AAGACCCCCT CGGGTACAGT GGGATTTTTC 480 CCTCCAAAGT GGTGGAGCCG CATAAAATCA AAACCCACGA GGCCCGCTCA CGTGCCGGTT 540 GCCCCGATCT CAATGTAGGC GGCTGCCGAC GCCGCACCTG CTCGGCCGGC CACTGCGGCT 600 GAGCGCCGCG CAGCCAGCGA TCGCGAGGCC CCGGGGGACG CGCCCAGCCC CGCCAAGCCC 660 GCCTCGCACC GCTACCCCGG AGGGCGGCGG CCGAGCGGGA AGGAAAGAGA GGGGAGGGGA 720 GGGAGGGGAG GGGAGGAGCG GCCCCGCCCG GCTAGGCGAG GCGAGGCTTG CCGCCCCTCC 780 ATTCGGACCC AAAAGAAAGC 800
|
| |
|
|
|